Armata Pharmaceuticals, Inc. — Director's Dealing 2004

May 24, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2004-05-20

Reporting Person: LACASSE LOUIS P (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-05-20	Stock Option (right to buy)	$1.3100	A	20000.0000	Acquired	2014-05-20	Common Stock (20000.0000)	Direct

Footnotes

F1: Such option is 100% vested and exercisable on 5/20/05, subject to the provision of continued service by the optionee to the issuer.

F2: Price is not applicable.